Dr. Reddy's Reports Q1 FY27 Consolidated Results and Announces Global Biologics Head Appointment
Dr. Reddy's Laboratories Ltd. announced its consolidated financial results for the quarter ended June 30, 2026, reporting revenues of 80,705 million INR. The company also confirmed the appointment of Dr. Sridevi Khambhampaty as Global Head of Biologics and detailed the appointment of M/s Deloitte Haskins & Sells, LLP as the Independent Registered Public Accounting Firm.The results for the quarter reflected a decline in consolidated revenues year-over-year but noted underlying double-digit growth in the base business across various geographies. The company also reported specific operational impacts related to production and market...